Dr Emil Andrei Cochino is a Specialist in Public Health and Health Services Management. He has been a scientific officer at EMA from 2009, and is working in the Human Medicines Department as a Scientific Senior Specialist (Risk Management), where he is responsible for peer-reviewing risk management plans for Advanced Therapy Medicinal Products. Furthermore, he is overseeing the revision 3 update of GVP Module V – Risk Management Systems and is coordinating the Agency’s transparency efforts for RMPs.

Maria Santos has a Pharmaceutical Sciences master degree. She has joined the EMA in 2018 and is working in the Human Medicines Department as a Product Lead and Risk Management Specialist in the Vaccines and Therapies for Infectious Diseases office while collaborating with the revision 3 update of GVP Module V – Risk Management Systems.

Behija Hudina has a University Master degree in Experimental Biology from the Faculty of Science at University of Zagreb. She joined the Croatian Agency for Medicinal Products and Medical Devices (HALMED), Department for Pharmacovigilance and Rational Pharmacotherapy in 2024 and currently works as a pharmacovigilance assessor. She also has previous 10 years of pharmacovigilance experience from working with various CROs.

Željana Margan Koletic joined the Croatian Agency for Medicinal Products and Medical Devices (HALMED) five years ago as an assessor in the pharmacovigilance department. She graduated in 2010 from the Faculty of Pharmacy and Biochemistry at University of Zagreb and she worked for several years as a community pharmacist. She participated in several pharmacovigilance projects and was a guest lecturer at University of Zagreb. Currently, she is working as Principal Coordinator for PSUR, DSUR and RMP assessment at HALMED and she is finalizing her thesis about biologicals and biosimilars at postgraduate specialist study “Clinical pharmacy” at University of Zagreb. Since 2016 she is a Croatian member of Pharmacovigilance Risk Assessment Committee.